Another drug to help patients with obesity-related conditions lose weight has been approved by the U.S. Food and Drug Administration (FDA). The approval of Zepbound
On Saturday, Oct. 21, 2023, Cardiometabolic Health Congress (CMHC) celebrated the final day of its 18th Annual Conference, Social Determinants and Digital Advances in Cardiorenal
The third day of Social Determinants and Digital Advances in Cardiorenal Metabolic Health, the 18th Annual Cardiometabolic Health Congress (CMHC), delivered insights on selecting and
The cardiorenal metabolic education continued on Thursday, Oct. 19, 2023, when the 18th Annual Cardiometabolic Health Congress (CMHC) launched its second day of sessions at
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Cardiometabolic Health Congress1801 N Military Trail, Ste 110Boca Raton, FL, 33431
Copyright © 2023, Cardiometabolic Health Congress. All Rights Reserved.